Total assets have plummeted from $73.8M in 2024Q4 to $12.3M in 2026Q1, indicating a rapid dissipation of the capital buffer available to support future operations.
| Cash & Short Term Investments | 26.56K | 2.93K | 28.21K | 580.72K |
| Cash & Due from Banks | 18.52K | 2.93K | 28.21K | 580.72K |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Total Investments | 12.28M | 12.1M | 73.78M | 69.89M |
| Investments Growth % | -230.83% | -83.6% | 5.57% | - |
| Long-Term Investments | 114.33M | 12.1M | 73.78M | 69.89M |
| Accounts Receivables | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| PP&E (Net) | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 0 | 0 | -1 |
| Total Current Assets | 18.71K | 2.93K | 30.38K | 580.72K |
| Total Non-Current Assets | 12.28M | 12.1M | 73.78M | 69.89M |
| Total Assets | 12.29M | 12.1M | 73.81M | 70.47M |
| Asset Growth % | -230.99% | -83.6% | 4.75% | - |
| Return on Assets (ROA) | 3.22% | 2.47% | 3.54% | 0.24% |
| Accounts Payable | 0 | 0 | 0 | 0 |
| Total Debt | 2.09M | 2.02M | 227.7K | 0 |
| Net Debt | 2.07M | 2.02M | 199.49K | -580.72K |
| Long-Term Debt | 0 | 0 | 0 | 0 |
| Short-Term Debt | 2.09M | 2.02M | 227.7K | 0 |
| Other Liabilities | 690K | 690K | 690K | 690K |
| Total Current Liabilities | 3.52M | 3.37M | 816.99K | 24.84K |
| Total Non-Current Liabilities | 690K | 690K | 690K | 690K |
| Total Liabilities | 4.21M | 4.06M | 1.51M | 714.84K |
| Total Equity | 8.09M | 8.04M | 72.31M | 69.76M |
| Equity Growth % | -252.25% | -88.88% | 3.66% | - |
| Equity / Assets (Capital Ratio) | 65.77% | 66.44% | 97.96% | 98.99% |
| Return on Equity (ROE) | 3.69% | 2.64% | 3.59% | 0.25% |
| Book Value per Share | 7.77 | 1.99 | 8.01 | 7.73 |
| Tangible BV per Share | 7.77 | 1.99 | 8.01 | 7.73 |
| Common Stock | 12.28M | 12.1M | 73.78M | 69.89M |
| Additional Paid-in Capital | 0 | 0 | 0 | 0 |
| Retained Earnings | -4.19M | -4.06M | -1.48M | -134.34K |
| Accumulated OCI | 0 | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Preferred Stock | 0 | 0 | 0 | 0 |
Immediate going concern liquidity
As reported in financial statements, AFJK's total assets have plummeted from $73.8M in 2024Q4 to $12.3M by 2026Q1, a contraction that suggests the entity is liquidating its investment portfolio to cover operational overhead rather than preserving capital for a potential business combination.
The consistent decline in total assets indicates a lack of organic growth and a potential erosion of the entity's core purpose as a shell vehicle. Investors should monitor whether the remaining $12.3M in assets can sustain the company's listing requirements or if further divestment is imminent.
Based on the company's reported figures, cash and bank balances have dwindled to a nominal $2,929 as of 2025Q4, which represents a near-total depletion of liquid resources and highlights the extreme vulnerability of the firm's current financial position.
This level of cash is insufficient for standard administrative operations, suggesting that the entity may be relying on sponsor support or deferring critical liabilities. The lack of liquidity appears to severely limit management's ability to pursue any meaningful acquisition strategy in the near term.
According to recent SEC filings, the company's equity has declined from $72.3M in 2024Q4 to $8.1M in 2026Q1, reflecting a significant reduction in the capital buffer available to absorb potential losses or fund future business combination activities.
The rapid decline in equity relative to assets suggests that the firm is consuming its capital base at an unsustainable rate. This trend may indicate that the entity is effectively liquidating its value, leaving little room for error in its search for a viable merger partner.
Data from the most recent quarterly reports indicates that nearly the entire asset base is comprised of investment securities, which, given the lack of liquidity, may suggest that these assets are either illiquid or restricted, further complicating the firm's ability to meet immediate obligations.
The reliance on investment securities as the primary asset class, coupled with the near-zero cash balance, suggests a potential duration or liquidity mismatch. This structure warrants further investigation into the nature of these securities and whether they can be readily converted to cash to support the entity's ongoing viability.
Quick answers to the most common questions about buying AFJK stock.
As of 2025, Aimei Health Technology Co., Ltd (AFJK) had total assets of $12.1M including $0.0M in current assets.
Aimei Health Technology Co., Ltd (AFJK) carries total debt of $2.0M. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Aimei Health Technology Co., Ltd (AFJK) has total shareholders' equity (book value) of $8.0M ($1.99 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Aimei Health Technology Co., Ltd (AFJK) reported a current ratio of 0.00x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.